CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis Cristina CapuanoChiara PighiRicciarda Galandrini Original Article Open access 16 January 2020 Pages: 501 - 512
High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma Jeroen MeliefYago Pico de CoañaRolf Kiessling Original Article Open access 17 January 2020 Pages: 513 - 522
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma Svenja Wagener-RyczekMax SchoemmelAlexander Quaas Original Article Open access 20 January 2020 Pages: 523 - 533
Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma Xiaofeng LiYufan ZhangWengui Xu Original Article 21 January 2020 Pages: 535 - 548
The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma Chi-Maw LinLong-Wei LinYi-Ling Ye Original Article 22 January 2020 Pages: 549 - 558
The neutrophil–lymphocyte ratio and locoregional melanoma: a multicentre cohort study Alyss V. RobinsonClaire KeebleRyckie G. Wade Original Article Open access 23 January 2020 Pages: 559 - 568
Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model James T. GordyKun LuoRichard B. Markham Original Article 24 January 2020 Pages: 569 - 580
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors Emma J. de RuiterReinout H. de RoestStefan M. Willems Original Article Open access 24 January 2020 Pages: 581 - 591
Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength Karin SchilbachNaomi KrickebergHisayoshi Hashimoto Original Article Open access 25 January 2020 Pages: 593 - 610
PKCζ mediated anti-proliferative effect of C2 ceramide on neutralization of the tumor microenvironment and melanoma regression Sweta GhoshSubir Kumar JuinSubrata Majumdar Original Article 30 January 2020 Pages: 611 - 627
Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition Jochen GreinerMarlies GötzVanessa Schneider Original Article 04 February 2020 Pages: 629 - 640
Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model Brian W. SimonsFabiana CannellaRaphael P. Viscidi Original Article 04 February 2020 Pages: 641 - 651
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization Luca MastracciVincenzo FontanaMaria Pia Pistillo Original Article 05 February 2020 Pages: 653 - 662
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors Mikiya IshiharaYasutaka TonoHiroshi Shiku Clinical Trial Report Open access 24 January 2020 Pages: 663 - 675
International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany Philipp BeckhoveMatthias EdingerHinrich Abken Meeting Report Open access 02 March 2020 Pages: 677 - 682